(TCS) shares traded at ₹3,120 at 11:50 AM on Thursday, down 1.18 per cent from the previous close of ₹3,157.20, The company announced a strategic partnership with Philippines pharmaceutical major Unilab Inc.
The stock opened at ₹3,145 and has traded in a range of ₹3,101.20 to ₹3,146.50 during the session, with a traded volume of 13.07 lakh shares worth ₹408.01 crore. The decline comes as broader market sentiment weighs on the major despite the positive corporate development.
TCS announced it will help Unilab transition from legacy enterprise resource planning systems to a modern cloud-based digital platform using SAP S/4HANA on RISE with cloud infrastructure. The IT services giant will handle end-to-end implementation, including strategy, design, system implementation, data migration and change management.
Unilab, one of the Philippines’ largest pharmaceutical companies with an 80-year legacy, operates extensive distribution networks serving thousands of trade customers across 18 nations. The modernisation aims to streamline business processes, improve resilience and enhance compliance through unified cloud platforms.
TCS has maintained presence in the Philippines since 2008, serving clients across telecom, banking, real estate and airlines sectors. The company has been recognised as a Top Employer in the Philippines from 2017 to 2024.
The stock remains well below its 52-week high of ₹4,592.25 hit in August 2024, though above the 52-week low of ₹2,991.60 recorded earlier this month.